Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Market Closed - NYSE Other stock markets 01:30:02 03/07/2026 am IST			5-day change	1st Jan Change
11.46 ^USD	-0.95%		+3.99%	-28.51%

02/07	Core Laboratories Inc.(NYSE:CLB) dropped from S&P Composite 1500	CI
02/07	Core Laboratories Inc.(NYSE:CLB) dropped from S&P 600	CI

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

a9417ea447c.6p8M6Nlw5ERVCQZ8YDW021i1HtcOC2rY90qUlFH083Q.r9Vgnr4hqBc7fWdMIkzAmj2Cc548XBiwlAilp2KrtCC950aYtimnCxRKVw~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

12/25/12	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
06/25/06	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/24/25	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/24/25	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/24/15	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
29/24/29	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/23/18	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
31/23/31	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/23/30	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
01/23/01	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
01/23/01	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
28/23/28	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
18/23/18	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
07/23/07	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
09/23/09	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
07/22/07	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/22/26	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
02/22/02	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
01/22/01	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
15/22/15	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
02/22/02	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/22/18	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT
11/22/11	Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CORE LABORATORIES INC.	-			+38.16%
SGS SA				+3.88%
UL SOLUTIONS INC.				+12.33%
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.				+35.59%
EMTEK (SHENZHEN) CO., LTD.		-	-	-
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.		-	-	+67.46%
TIC SOLUTIONS, INC.				+45.32%
GRG METROLOGY & TEST GROUP CO., LTD.				+42.5%
Average				+35.04%
Weighted average by Cap.				+14.43%